Splitting the dose, as mentioned earlier (e.g., 250 mcg in the morning and 250 mcg at night), is a strategy we frequently see
Antioxidant activities: According to Indonesia research, engineered Lactococcus lactis as a delivery vehicle for BPC-157 demonstrates antioxidant activity, reducing ROS production in cell models (5)
5-HTP 5-Hydroxytryptophan is a precursor to serotonin, and approximately 95% of the body serotonin is produced in the gut where it plays a critical role in regulating motility
Similarly, GHK-Cu showed notable findings in mouse models of ARDS, reducing TNF- and IL-6 expression, and demonstrating a protective effect against this rapid and potentially fatal inflammatory lung condition
Monitoring focuses on glucose trends, kidney/liver context, lipids, and symptoms tied to reduced intake or GI effects
A single study does not create a new standard of care